The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amoxicillin Centrient 500 mg hard capsules



Centrient Pharmaceuticals Netherlands B.VPA1832/001/002

Main Information

Trade NameAmoxicillin Centrient 500 mg hard capsules
Active SubstancesAmoxicillin (as trihydrate)
Dosage FormCapsule, hard
Licence HolderCentrient Pharmaceuticals Netherlands B.V
Licence NumberPA1832/001/002

Group Information

ATC CodeJ01CA Penicillins with extended spectrum
J01CA04 amoxicillin

Status

License statusAuthorised
Licence Issued26/07/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back